Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Supportive ICU Care and Complication Prevention in Toxicology

Supportive ICU Care and Complication Prevention

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Lesson Objective

Recommend appropriate supportive care and monitoring to manage complications associated with toxic alcohol and small-molecule poisonings and their treatments.

1. Introduction to Supportive Care Principles

Supportive ICU care in toxic alcohol poisoning centers on the rapid stabilization of airway, breathing, and circulation (the ABCs) amidst severe metabolic acidosis. The primary goal is to proactively prevent secondary organ injury while specific treatments like antidotes and dialysis are initiated. This involves correcting high-anion-gap metabolic acidosis through optimized ventilation, judicious fluid administration, and, when necessary, extracorporeal removal of the toxin.

Key interventions include the use of balanced crystalloids over normal saline to avoid worsening acidosis with a hyperchloremic component, implementation of low-tidal-volume ventilation to protect the lungs, goal-directed hemodynamic support, and standardized prophylaxis bundles to prevent common ICU complications.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Early Goal-Directed Therapy

Early goal-directed therapy that targets a lactate clearance of more than 10% within the first 2 hours of resuscitation is strongly correlated with improved outcomes in critically ill patients, including those with severe poisoning.

2. Airway and Respiratory Support

In severe toxic alcohol poisoning, the combination of profound metabolic acidosis and central nervous system depression can overwhelm the patient’s compensatory hyperventilation. This leads to respiratory muscle fatigue and eventual collapse. Therefore, elective protection of the airway and implementation of lung-protective ventilation are essential components of management.

Indications for Intubation and Mechanical Ventilation

  • Depressed level of consciousness (Glasgow Coma Scale ≤ 8) or inability to protect the airway from aspiration.
  • Evidence of respiratory muscle fatigue in the setting of severe acidemia (e.g., pH ≤ 7.20).
  • Refractory hypoxemia or acute respiratory distress syndrome (ARDS), defined as a PaO₂/FiO₂ ratio < 200.

Rapid-Sequence Induction (RSI) and Sedation

For RSI, etomidate (0.2–0.3 mg/kg IV) is often preferred for its hemodynamic stability. In patients with pre-existing hypotension, ketamine (1–2 mg/kg IV) can be a better choice. Paralysis is typically achieved with succinylcholine (1–1.5 mg/kg IV) unless contraindicated. For post-intubation sedation, propofol or dexmedetomidine are favored to minimize delirium.

Ventilator Settings and Monitoring

Ventilator settings must be tailored to the patient’s acid-base status:

  • Tidal Volume: 6 mL/kg of predicted body weight with a target plateau pressure ≤ 30 cm H₂O.
  • Respiratory Rate: A high rate (20–25 breaths/min) is often needed to “blow off” CO₂ and help correct the metabolic acidosis, aiming for a pH ≥ 7.20.
  • PEEP and FiO₂: Titrated according to ARDSNet guidelines to maintain SpO₂ > 92%.

Daily sedation interruptions, spontaneous breathing trials, and diligent monitoring for barotrauma are critical to minimize ventilator-associated complications.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Proactive Airway Management

Elective intubation before the onset of frank respiratory collapse is a key strategy to prevent the complications associated with an emergent, uncontrolled airway procedure, such as aspiration, hypoxia, and cardiovascular collapse.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Sedation Strategy

Sedation strategies should carefully balance the need to control agitation and facilitate mechanical ventilation against the risks of hemodynamic instability and ICU delirium. Using validated sedation scales and daily interruptions can optimize this balance.

3. Hemodynamic Management

Toxic alcohol poisonings often cause vasodilation and myocardial depression, leading to shock. The goal of hemodynamic management is to restore tissue perfusion with targeted fluid and vasopressor therapy while avoiding the complications of fluid overload, which can worsen pulmonary edema and organ dysfunction.

Fluid and Vasopressor Therapy

Initial resuscitation involves boluses of a balanced crystalloid solution (e.g., Lactated Ringer’s) at 10–20 mL/kg, titrated to clinical endpoints like a mean arterial pressure (MAP) ≥ 65 mm Hg and urine output ≥ 0.5 mL/kg/hr. If hypotension persists, vasopressors are required.

Vasopressor Selection Flowchart for Toxicologic Shock A flowchart showing the decision-making process for selecting vasopressors. It starts with hypotension. If bradycardia is present, dopamine is considered. Otherwise, norepinephrine is the first-line agent. For refractory shock, vasopressin is added. Hypotension (MAP < 65 mmHg) Bradycardia? Yes Dopamine No Norepinephrine (First-line) Refractory? Yes Add Vasopressin
Figure 1: Vasopressor Selection Algorithm. Norepinephrine is the first-line agent for most toxicologic shock. Vasopressin is added for refractory shock, while dopamine is reserved for cases with significant bradycardia.

Monitoring Perfusion

Effective monitoring is key. This includes continuous arterial pressure measurement via an indwelling catheter, along with serial assessment of lactate clearance and central venous oxygen saturation (ScvO₂). The clinical exam remains vital, focusing on mental status, capillary refill time, skin temperature, and urine output as global indicators of tissue perfusion.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Fluid Balance Tightrope

The goal is to optimize perfusion without precipitating pulmonary or interstitial edema. After initial fluid boluses, if hypotension persists, it is often better to start vasopressors early rather than administering large volumes of additional fluid, especially if there are signs of volume overload.

4. Prevention of ICU-Related Complications

Critically ill poisoned patients are at high risk for common ICU-acquired complications. Standard prophylactic measures, guided by daily risk assessment, can significantly reduce the incidence of venous thromboembolism (VTE), stress-related mucosal bleeding, and device-associated infections.

Table 1. Standard Prophylaxis Strategies in the ICU
Complication Preferred Intervention Dosing / Protocol
Venous Thromboembolism (VTE) Enoxaparin or Unfractionated Heparin Enoxaparin 40 mg SC q24h (30 mg if CrCl < 30); UFH 5,000 U SC q8h
Stress-Related Mucosal Bleeding Pantoprazole or Ranitidine Pantoprazole 40 mg IV q24h; Ranitidine 50 mg IV q8h
Central Line-Associated Infection (CLABSI) Central Line Care Bundle Maximal barriers, chlorhexidine skin prep, daily line necessity review
Ventilator-Associated Pneumonia (VAP) Ventilator Care Bundle Head-of-bed 30-45°, sedation breaks, subglottic suction, oral care
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Daily Reassessment

Prophylaxis is not indefinite. Conduct daily risk-benefit assessments for each intervention. Discontinue prophylaxis (e.g., for stress ulcers) once major risk factors resolve to minimize adverse effects and cost.

5. Management of Iatrogenic Complications

The very treatments used to save the patient—such as extracorporeal therapies and antidotes—can provoke their own set of complications. Anticipatory monitoring and prompt correction of these iatrogenic issues, particularly electrolyte derangements, are crucial.

Electrolyte Disturbances Post-Dialysis

Hemodialysis can lead to rapid shifts in electrolytes. Key issues include:

  • Hypokalemia: Prevent by using a dialysate K⁺ concentration of 2–4 mEq/L and maintaining serum K⁺ ≥ 4.0 mEq/L with IV repletion as needed.
  • Hypocalcemia: Monitor ionized calcium and replete with IV calcium gluconate (1–2 g) to target an ionized Ca²⁺ > 1.0 mmol/L.

Drug-Induced Organ Effects

  • Ethanol Infusion: Continuous infusions of ethanol, used as an antidote for toxic alcohol poisoning, can cause hypotension, respiratory depression, and hypertriglyceridemia. Triglyceride levels should be checked daily.
  • Propofol Infusion Syndrome (PRIS): In patients on high-dose or prolonged propofol infusions, watch for unexplained metabolic acidosis, rhabdomyolysis (elevated CK), and arrhythmias. If suspected, the infusion must be stopped immediately.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Customize the Dialysate

Do not use a “one-size-fits-all” dialysate. Customize the dialysate composition (especially potassium and bicarbonate) based on the patient’s pre-dialysis labs to prevent abrupt and dangerous shifts in electrolytes and pH.

6. Multidisciplinary Goals-of-Care Discussions

In cases of severe poisoning with uncertain prognosis, early involvement of ethics and palliative care specialists is vital. These consultations help ensure that invasive or prolonged interventions align with the patient’s values and goals. Clear communication with the patient and their family about the risks, benefits, and likely recovery trajectory is the cornerstone of shared decision-making. Important decisions, such as code status and the designation of a surrogate decision-maker, should be documented clearly and reinforced during daily rounds.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Palliative Care is Not Just End-of-Life Care

Early palliative care involvement provides an extra layer of support for patients and families, focusing on symptom management and communication. Studies show this approach can reduce nonbeneficial treatments and improve family satisfaction without compromising survival.

7. Monitoring and Reassessment

Dynamic reassessment is the key to managing critically ill poisoned patients. Frequent clinical and laboratory evaluations guide the timely escalation or de-escalation of ICU support. Initially, this means serial assessments of arterial blood gases, lactate, electrolytes, and renal and neurologic function every 4–6 hours. Once the patient stabilizes, this interval can be extended to every 8–12 hours.

Criteria for Action

  • Escalation of Care: Worsening parameters, such as a MAP < 65 mm Hg, lactate clearance < 10% over 2 hours, or a falling pH < 7.20, should trigger an immediate re-evaluation and potential escalation of therapy (e.g., increasing vasopressors, considering dialysis).
  • De-escalation of Care: Improving parameters, such as a pH > 7.30, stable hemodynamics off vasopressors for over 6 hours, and successful spontaneous breathing trials, are criteria to begin weaning support.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Standardize Reassessment

Standardizing reassessment intervals and creating clear thresholds for action (e.g., via a nursing protocol or rounding checklist) helps prevent both clinical inertia (undertreatment) and the failure to wean therapies promptly (overtreatment).

8. Clinical Pearls and Pitfalls

This section summarizes the most critical take-home points for providing supportive care in the ICU for poisoned patients.

Key Pearls

  • Always use balanced crystalloids (e.g., Lactated Ringer’s) for fluid resuscitation to avoid contributing to hyperchloremic metabolic acidosis.
  • Implement daily sedation interruptions and spontaneous breathing trials to minimize ventilator days, delirium, and VAP.
  • Tailor VTE and stress ulcer prophylaxis to patient-specific risk factors and reassess the need daily.
  • Individualize dialysate electrolyte composition to preempt dialysis-related imbalances.
  • Engage multidisciplinary teams (toxicology, nephrology, ethics, palliative care) early for complex cases to optimize outcomes.

Common Pitfalls

  • Delaying intubation until respiratory collapse is imminent.
  • Aggressive fluid resuscitation in the setting of shock, leading to pulmonary edema, without an early transition to vasopressors.
  • Failing to monitor for and correct electrolyte abnormalities caused by dialysis or antidote therapy.
  • Continuing prophylactic medications long after the patient’s risk factors have resolved.

References

  1. Megarbane B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005;31(2):189–195.
  2. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for management of pain, agitation, and delirium in ICU patients. Crit Care Med. 2013;41(1):263–306.
  3. Dumitru O, et al. Dyselectrolytemia-management and implications in hemodialysis. Int J Nephrol Renovasc Dis. 2020;13:337–346.
  4. Dilaver RG, et al. Personalizing dialysate electrolytes in the dialysis prescription. Clin Kidney J. 2024;17(1):sfad210.
  5. Kang SH, et al. Management for electrolyte disturbances during continuous renal replacement therapy. Electrolyte Blood Press. 2022;20(4):109–117.